Growth Metrics

Calidi Biotherapeutics (CLDI) Debt to Equity (2022 - 2025)

Calidi Biotherapeutics' quarterly Debt to Equity came in at $0.05 in Q4 2025, down 53.05% year-on-year from $0.11 in Q4 2024, and up 27.66% quarter-over-quarter from $0.04 in Q3 2025.

Calidi Biotherapeutics has reported Debt to Equity for 4 years, with the latest figure at $0.05 in Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 53.05% year-over-year to $0.05; the trailing twelve-month figure through Dec 2025 stood at $0.05 (down 53.05% YoY), and the FY2025 full-year result was $0.05, down 53.05% from the prior year.
  • Debt to Equity for Q4 2025 stood at $0.05, up from $0.04 in the prior quarter.
  • The five-year high for Debt to Equity was $240.85 in Q2 2025, with the low at -$2.7 in Q3 2023.
  • Average Debt to Equity over 4 years is $19.84, with a median of -$0.01 recorded in 2024.
  • Year-over-year, Debt to Equity plunged 1161.77% in 2023 and soared 1341542.26% in 2025.
  • Tracing CLDI's Debt to Equity over 4 years: stood at -$0.02 in 2022, then sank by 1161.77% to -$0.25 in 2023, then soared by 145.3% to $0.11 in 2024, then tumbled by 53.05% to $0.05 in 2025.
  • The last three Debt to Equity figures came in at $0.05 (Q4 2025), $0.04 (Q3 2025), and $240.85 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 0.06
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -
10 Calidi Biotherapeutics - - - 0.05

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.05
Sep 30, 2025 0.04
Jun 30, 2025 240.85
Dec 31, 2024 0.11
Sep 30, 2024 -0.02
Jun 30, 2024 -0.02
Mar 31, 2024 -0.01
Dec 31, 2023 -0.25
Sep 30, 2023 -2.70
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 -0.02